Table 1 Epidemiological characteristics of patients and control group
From: Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer
Patients (n = 110) | Controls (n = 40) | p | ||||
|---|---|---|---|---|---|---|
n | % | n | % | |||
Sex | female | 8 | 7.3 | 2 | 5.0 | >0.05 |
male | 102 | 92.7 | 38 | 95.0 | ||
Age | <49 | 12 | 10.9 | 6 | 15.0 | >0.05 |
50–59 | 46 | 41.8 | 16 | 40.0 | ||
>60 | 52 | 47.3 | 18 | 45.0 | ||
Place of residence | urban | 72 | 65.5 | 28 | 70.0 | >0.05 |
rural | 38 | 34.5 | 12 | 30.0 | ||
Smoking | yes | 94 | 85.5 | 36 | 90.0 | >0.05 |
no | 16 | 14.5 | 4 | 10.0 | ||
Alcohol abuse | yes | 50 | 45.5 | 14 | 35.0 | >0.05 |
no | 60 | 54.5 | 13 | 65.0 | ||
EBV DNA | positive | 58 | 52.7 | 10 | 25.0 | <0.001 |
negative | 52 | 47.3 | 30 | 75.0 | ||